Tickers

1. Composite Trajectory Verdict

Given LW's capital-intensive manufacturing model with significant working capital dynamics, all three statements carry roughly equal weight: the income statement reveals margin trajectory, the cash flow statement shows conversion of earnings to cash after capex, and the balance sheet reflects leverage and liquidity management.

Composite Trajectory: Mixed

The income statement shows clear deterioration across three fiscal years: net sales were essentially flat ($6.47B → $6.45B → $6.61B) while gross profit fell 23% ($1.77B → $1.40B → $1.36B), operating income fell 45% ($1.07B → $665M → $591M), and net income fell 60% ($726M → $357M → $290M) (10-K FY2026, Consolidated Statements of Earnings). Conversely, cash generation improved markedly: operating cash flow rose 18% over three years ($798M → $868M → $943M) and free cash flow turned from negative to strongly positive as capex declined from $930M to $403M (10-K FY2026, Consolidated Statements of Cash Flows). The balance sheet also strengthened: total debt fell $220M, inventories dropped $67M, and equity rose $87M (10-K FY2026, Consolidated Balance Sheets). Quarterly YoY comparisons confirm the earnings deterioration (Q3 FY2026 net income $54M vs $146M) while operating cash flow YTD rose 23% to $596M (10-Q Q3 FY2026, Consolidated Statements of Cash Flows).

2. Red Flags

• GAAP earnings-cash divergence: Net income fell 60% over three years while operating cash flow rose 18% ($726M→$290M vs $798M→$943M) (10-K FY2026, Consolidated Statements of Earnings/Cash Flows).
• Gross margin compression: Gross margin declined from 27.3% (FY2024) to 21.7% (FY2025) to 20.6% (FY2026) (10-K FY2026, Consolidated Statements of Earnings).
• International segment profitability collapse: International Segment Adjusted EBITDA fell 55% from $257.6M to $114.7M, driven by a $33.1M raw potato write-off, lower utilization, and Argentina start-up costs (10-K FY2026, MD&A Results of Operations).
• Recurring restructuring charges: "Cost Savings Program and Restructuring expenses" totaled $185.8M (FY2025) and $111.6M (FY2026) across two consecutive years (10-K FY2026, Note 4).
• Goodwill impairment risk disclosed: The International reporting unit's fair value "is more sensitive to changes in projected operating results... lower-than-expected sales or profitability and/or an increase in the WACC could reduce the International reporting unit's estimated fair value and result in a goodwill impairment" (10-K FY2026, Critical Accounting Estimates).
• Effective tax rate spike: Q3 FY2026 effective tax rate jumped to 35.9% from 28.3% in Q3 FY2025; full-year rate rose to 30.6% from 28.6% (10-Q Q3 FY2026, MD&A; 10-K FY2026, MD&A).
• Accrued liabilities surge: Accrued liabilities rose 17% to $482M, driven by compensation/benefits accruals increasing 55% to $162M (10-K FY2026, Note 7; Consolidated Balance Sheets).
• Pension termination charge: $14.2M pre-tax settlement charge in FY2026 (10-K FY2026, Note 1; MD&A Non-GAAP reconciliations).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Overall Assessment: Across three fiscal years, revenue was flat to slightly up while every profitability metric declined. Net sales grew 2% in FY2026 to $6.61B but were only 2% above FY2024's $6.47B (10-K FY2026, Consolidated Statements of Earnings). Gross profit fell 23% from $1.77B to $1.36B, with gross margin dropping 670 basis points to 20.6%. Operating income fell 45% from $1.07B to $591M. Net income fell 60% from $726M to $290M. Diluted EPS fell from $4.98 to $2.08. The FY2026 53rd week contributed $127M to sales and $29M to Adjusted EBITDA, masking underlying weakness (10-K FY2026, MD&A). Quarterly YoY confirms the trend: Q3 FY2026 net income of $54M was down 63% from $146M in Q3 FY2025 on only 3% higher sales, with gross profit down 21% and operating income down 49% (10-Q Q3 FY2026, Consolidated Statements of Earnings). YTD Q3 net income fell 24% to $180M on 1% higher sales (10-Q Q3 FY2026, Consolidated Statements of Earnings).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Overall Assessment: Operating cash flow has increased for three consecutive years: $798M (FY2024) → $868M (FY2025) → $943M (FY2026) (10-K FY2026, Consolidated Statements of Cash Flows). Capital expenditures declined sharply from $930M to $403M as major expansion projects (Netherlands, US, Argentina) were completed, turning free cash flow from -$131M to +$540M (10-K FY2026, Consolidated Statements of Cash Flows; MD&A Liquidity). Investing cash outflows fell 41% year-over-year to $380M. Financing activities used $569M in FY2026 versus $225M in FY2025, reflecting $241M net debt repayments, $208M dividends, and $113M share repurchases (10-K FY2026, Consolidated Statements of Cash Flows). YTD Q3 FY2026 operating cash flow rose 23% to $596M vs $485M in prior year, with investing outflows down 57% to $238M (10-Q Q3 FY2026, Consolidated Statements of Cash Flows). Cash conversion remains strong despite earnings decline.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Overall Assessment: The balance sheet strengthened across key metrics from May 2025 to May 2026. Total debt and financing obligations fell from $4.15B to $3.93B, with short-term borrowings dropping 33% from $371M to $249M and long-term debt declining 2% to $3.60B (10-K FY2026, Consolidated Balance Sheets; Note 8). Inventories decreased 6% from $1.04B to $969M, driven by finished goods reduction from $756M to $704M (10-K FY2026, Note 1). Total current liabilities fell 4% to $1.42B despite a 17% rise in accrued liabilities to $482M (10-K FY2026, Consolidated Balance Sheets). Stockholders' equity rose 5% to $1.82B from $1.74B, supported by $290M net income and $77M foreign currency translation gains, partially offset by $208M dividends and $113M buybacks (10-K FY2026, Consolidated Statements of Stockholders' Equity). The current ratio improved from 1.38x to 1.42x. Revolving credit facility availability stood at $1.28B at year-end (10-K FY2026, MD&A Liquidity).

6. Data Gaps

• Standalone Q4 FY2026 results (only full-year and YTD Q3 provided)
• Quarterly GAAP segment operating income (only Segment Adjusted EBITDA disclosed quarterly)
• FY2025 quarterly data for Q1, Q2, Q4 (only Q3 FY2025 10-Q provided)
• Detailed capex breakdown by segment and project
• Cash tax payments by quarter (only annual disclosed in Note 3)
• Working capital days metrics (DSO, DIO, DPO) not explicitly disclosed
• Covenant compliance metrics (net leverage, interest coverage) not quantified in filings